We evaluated factors associated with subjective and objective sleepiness at baseline and
after 6 months of continuous positive airway pressure (CPAP) therapy in patients with …

Background: Obstructive sleep apnoea syndrome (OSAS) affects an estimated 2–4% of the
middle aged population. Meta-analyses of randomised controlled trials have shown that the …

Introduction Continuous positive airway pressure (CPAP) is currently the treatment of choice
for sleepiness in patients with obstructive sleep apnoea (OSA); however, adherence is often …

Rationale Placebo responses are complex psychobiological phenomena and often involve
patient expectation of benefit. With continuous positive airway pressure (CPAP) treatment of …

The percentage of compliant continuous positive airway pressure (CPAP)-treated apnoeic
patients that continue to experience residual excessive sleepiness (RES) is unknown. RES …

Some patients with obstructive sleep apnoea syndrome (OSAS; respiratory distress index
(RDI) of> 5 events· h− 1) experience residual excessive daytime subjective sleepiness …

Background: It is unclear whether continuous positive airway pressure (CPAP), the treatment
of choice for severe obstructive sleep apnoea (OSA), is effective at improving outcomes in …

BACKGROUND: Continuous positive airway pressure (CPAP) improves daytime sleepiness
in patients with obstructive sleep apnoea (OSA). The effect of CPAP on physical activity is …

There are limited data on the evolution of obstructive sleep apnoea (OSA) during continuous
positive airway pressure (CPAP) therapy and whether this treatment is required every night …

Almost all the information about the effect of continuous positive airway pressure (CPAP) in
patients with obstructive sleep apnoea (OSA) comes from clinical trials involving only middle …